Document Type
Editorial
Publication Date
1-1-2020
Abstract
The absurd edicts initially issued by several governors, including those of Michigan and New York, prohibiting physicians from ordering hydroxychloroquine for patients suspected of or diagnosed with COV-19 are reprehensible. Their reasoning is beyond the pale.
Hydroxychloroquine was first approved by the FDA in 1955 and has a remarkable safety record in its use as a preventative for malaria and in the treatment of several immunologic and/or light induced diseases. Its use came about serendipitously, and its mechanism of action is unclear, but the fact remains that it seems to work.
Recommended Citation
Parish, Lawrence Charles and Lambert, W Clark, "COVID-19, Serendipity, and Strange Interlude: Gloria in Absurdicum with an Apology to Ovid" (2020). Department of Dermatology and Cutaneous Biology Faculty Papers. Paper 135.
https://jdc.jefferson.edu/dcbfp/135
PubMed ID
32790609
Comments
This is the postprint version of the authors article published in Skinmed, 2020, Volume 18, Issue 3, Pages 143-144.
The final published version of the article can be found at the journal website, https://skinmedjournal.com/
Copyright: Pulse Marketing & Communications, LLC